Does growth hormone cause cancer?
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 115, doi. 10.1111/j.1365-2265.2005.02404.x
- By:
- Publication type:
- Article
Works matching IS 03000664 AND DT 2006 AND VI 64 AND IP 2
Results: 22
1
2
Growth hormone and cancer: are we asking the right questions?
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 122, doi. 10.1111/j.1365-2265.2006.02409.x
- By:
- Publication type:
- Article
3
Radioiodine therapy and age at menopause in patients with thyroid cancer.
- Published in:
- 2006
- By:
- Publication type:
- Letter
4
Three decades of clinical follow-up in 271 women with hyperprolactinaemia; macroprolactinaemia should be considered.
- Published in:
- 2006
- By:
- Publication type:
- Letter
5
Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 125, doi. 10.1111/j.1365-2265.2006.02433.x
- By:
- Publication type:
- Article
6
The tumour necrosis factor ( TNF)-α−308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 129, doi. 10.1111/j.1365-2265.2006.02434.x
- By:
- Publication type:
- Article
7
Only two amino acid substitutions of I236N and V237E in exon 6 are converted to the CYP21 gene in a Chinese patient with congenital adrenal hyperplasia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
8
Risk for severe hypoglycaemia with unawareness in GH-deficient patients during the insulin tolerance test.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 136, doi. 10.1111/j.1365-2265.2006.02436.x
- By:
- Publication type:
- Article
9
Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 141, doi. 10.1111/j.1365-2265.2006.02437.x
- By:
- Publication type:
- Article
10
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 146, doi. 10.1111/j.1365-2265.2006.02438.x
- By:
- Publication type:
- Article
11
Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 153, doi. 10.1111/j.1365-2265.2005.02440.x
- By:
- Publication type:
- Article
12
Thyrotoxic periodic paralysis and polymorphisms of sodium–potassium ATPase genes.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 158, doi. 10.1111/j.1365-2265.2005.02442.x
- By:
- Publication type:
- Article
13
Does birthweight predict adolescent adiponectin levels?
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 162, doi. 10.1111/j.1365-2265.2006.02443.x
- By:
- Publication type:
- Article
14
Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 169, doi. 10.1111/j.1365-2265.2006.02444.x
- By:
- Publication type:
- Article
15
Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 179, doi. 10.1111/j.1365-2265.2006.02445.x
- By:
- Publication type:
- Article
16
Magnetic resonance imaging, clinical manifestations, and management of Rathke's cleft cyst.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 184, doi. 10.1111/j.1365-2265.2006.02446.x
- By:
- Publication type:
- Article
17
Increase of interferon-γ-inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapy.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 189, doi. 10.1111/j.1365-2265.2006.02447.x
- By:
- Publication type:
- Article
18
Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 196, doi. 10.1111/j.1365-2265.2006.02448.x
- By:
- Publication type:
- Article
19
The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 203, doi. 10.1111/j.1365-2265.2006.02449.x
- By:
- Publication type:
- Article
20
Effectiveness and tolerability of 3-year lanreotide Autogel® treatment in patients with acromegaly.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 209, doi. 10.1111/j.1365-2265.2006.02450.x
- By:
- Publication type:
- Article
21
Low-dose ACTH (1 µg) salivary test: a potential alternative to the classical blood test.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 215, doi. 10.1111/j.1365-2265.2006.02451.x
- By:
- Publication type:
- Article
22
Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 2, p. 219, doi. 10.1111/j.1365-2265.2006.02452.x
- By:
- Publication type:
- Article